Cargando…

Impact of the national hepatitis B immunization program in China: a modeling study

BACKGROUND: Elimination of hepatitis B virus (HBV) is a striking challenge for countries with high or moderate disease burden. Therefore, using China as a practical case to share experiences for similar countries may accelerate the achievement of the WHO 2030 target of 90% reduction in HBV-related i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhixi, Li, Mengying, Hutton, David W., Wagner, Abram L., Yao, Ye, Zhu, Wenlong, Cao, Lingsheng, Tang, Shenglan, Pan, Jinhua, Wang, Yesheng, Zhao, Qi, Ren, Hong, Wang, Ying, Wang, Weibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552421/ https://www.ncbi.nlm.nih.gov/pubmed/36221140 http://dx.doi.org/10.1186/s40249-022-01032-5

Ejemplares similares

Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950–2018
por: Pan, Jinhua, et al.
Publicado: (2021)

Risk assessment and evaluation of China’s policy to prevent COVID-19 cases imported by plane
por: Pan, Jinhua, et al.
Publicado: (2020)

Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19
por: Pan, Jinhua, et al.
Publicado: (2022)

Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study
por: Zhu, Wenlong, et al.
Publicado: (2021)

Developing an effective and sustainable national immunisation programme in China: issues and challenges
por: Chen, Shu, et al.
Publicado: (2022)

Patterns of human social contact and mask wearing in high-risk groups in China
por: Zheng, Bo, et al.
Publicado: (2022)

Optimization of Vaccination Clinics to Improve Staffing Decisions for COVID-19: A Time-Motion Study
por: Wang, Xinyu, et al.
Publicado: (2022)

Ambient nitrogen dioxide pollution and spreadability of COVID-19 in Chinese cities
por: Yao, Ye, et al.
Publicado: (2021)

Temporal association between particulate matter pollution and case fatality rate of COVID-19 in Wuhan
por: Yao, Ye, et al.
Publicado: (2020)

No association of COVID-19 transmission with temperature or UV radiation in Chinese cities
por: Yao, Ye, et al.
Publicado: (2020)

ARIMA and ARIMA-ERNN models for prediction of pertussis incidence in mainland China from 2004 to 2021
por: Wang, Meng, et al.
Publicado: (2022)

The burden of hand, foot, and mouth disease among children under different vaccination scenarios in China: a dynamic modelling study
por: Liu, Zhixi, et al.
Publicado: (2021)

Association of particulate matter pollution and case fatality rate of COVID-19 in 49 Chinese cities
por: Yao, Ye, et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Utilization of Inpatient Mental Health Services in Shanghai, China
por: Li, Hao, et al.
Publicado: (2022)

Effects of contact tracing and nucleic acid testing on the COVID-19 outbreak in Zunyi, China: data-driven study using a branching process model
por: Feng, Jun, et al.
Publicado: (2023)

Epidemiologic trends of hepatitis A in different age groups and regions of China from 1990 to 2018: observational population-based study
por: Zheng, Bo, et al.
Publicado: (2021)

Factors That Impact Acceptance of COVID-19 Vaccination in Different Community-Dwelling Populations in China
por: Pan, Jinhua, et al.
Publicado: (2022)

Costs and health impact of delayed implementation of a national hepatitis B treatment program in China
por: Toy, Mehlika, et al.
Publicado: (2022)

Warmer weather unlikely to reduce the COVID-19 transmission: An ecological study in 202 locations in 8 countries
por: Pan, Jinhua, et al.
Publicado: (2021)

Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China
por: Toy, Mehlika, et al.
Publicado: (2015)

Vaccination Vehicles for COVID-19 Immunization — China, 2021
por: Lei, Hong, et al.
Publicado: (2021)

Progress Towards Hepatitis A Control and Prevention Through 2019: the National Immunization Program of China
por: Sun, Xiaojin, et al.
Publicado: (2020)

The way back home: Trading behaviours of foreign institutional investors in China amid the COVID-19 pandemic
por: Zhang, Jinhua, et al.
Publicado: (2021)

Effect of different interventions for latent tuberculosis infections in China: a model-based study
por: Wen, Zexuan, et al.
Publicado: (2022)

Increasing Coverage of Hepatitis B Vaccination in China: A Systematic Review of Interventions and Implementation Experiences
por: Wang, Shengnan, et al.
Publicado: (2016)

Epidemiology of Hepatitis E Virus in China: Results from the Third National Viral Hepatitis Prevalence Survey, 2005–2006
por: Jia, Zhiyuan, et al.
Publicado: (2014)

Urban health insurance reform and coverage in China using data from National Health Services Surveys in 1998 and 2003
por: Xu, Ling, et al.
Publicado: (2007)

Quantitative assessment of the effects of massive nucleic acid testing in controlling a COVID-19 outbreak
por: Zhu, Wenlong, et al.
Publicado: (2022)

Vaccine hesitancy and receipt of mandatory and optional pediatric vaccines in Shanghai, China
por: Ji, Mengdi, et al.
Publicado: (2022)

Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China
por: Yang, Shigui, et al.
Publicado: (2015)

Senior Research Scholars in China CDC’s National Immunization Program
por: Wang, Miao, et al.
Publicado: (2021)

Scaling up the national methadone maintenance treatment program in China: achievements and challenges
por: Yin, Wenyuan, et al.
Publicado: (2010)

Investigation of non-National Immunization Program vaccination intentions in rural areas of China
por: Wang, Xiuli, et al.
Publicado: (2023)

Cost-effectiveness of a national enterovirus 71 vaccination program in China
por: Wang, Wenjun, et al.
Publicado: (2017)

Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China
por: Chen, Shu, et al.
Publicado: (2020)

Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinoma
por: Xu, Yongkang, et al.
Publicado: (2022)

Direct Medical Costs of Hospitalizations for Cardiovascular Diseases in Shanghai, China: Trends and Projections
por: Wang, Shengnan, et al.
Publicado: (2015)

Multimorbidity among Two Million Adults in China
por: Wang, Xiaowen, et al.
Publicado: (2020)

Smoking Prevalence, Patterns, and Cessation Among Adults in Hebei Province, Central China: Implications From China National Health Survey (CNHS)
por: He, Huijing, et al.
Publicado: (2020)

Mobility patterns and associated factors among pregnant internal migrant women in China: a cross-sectional study from a National Monitoring Survey
por: Ji, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdaa3s1qg7f4tepa9lj7o7mq0a